- Home
- FENC vs PKOH Comparison
FENC vs PKOH Comparison
Compare FENC & PKOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FENC | PKOH |
|---|---|---|
| Founded | 1996 | 1907 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Industrial Specialties |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 299.5M |
| IPO Year | 2010 | 1994 |
Fundamental Metrics
Financial Performance| Metric | FENC | PKOH |
|---|---|---|
| Price | $7.44 | $23.28 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 1 |
| Target Price | $15.00 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 120.6K | 26.3K |
| Earning Date | 03-24-2026 | 03-04-2026 |
| Dividend Yield | N/A | ★ 2.12% |
| EPS Growth | ★ 96.67 | N/A |
| EPS | N/A | ★ 1.70 |
| Revenue | $47,538,000.00 | ★ $1,599,100,000.00 |
| Revenue This Year | N/A | $7.87 |
| Revenue Next Year | $70.78 | $3.42 |
| P/E Ratio | ★ N/A | $14.01 |
| Revenue Growth | ★ 123.69 | N/A |
| 52 Week Low | $4.68 | $15.52 |
| 52 Week High | $9.92 | $29.50 |
Technical Indicators
Market Signals| Indicator | FENC | PKOH |
|---|---|---|
| Relative Strength Index (RSI) | 41.25 | 35.28 |
| Support Level | $7.44 | $19.21 |
| Resistance Level | $8.19 | $23.05 |
| Average True Range (ATR) | 0.43 | 1.52 |
| MACD | -0.07 | -0.40 |
| Stochastic Oscillator | 11.79 | 19.46 |
Price Performance
Historical ComparisonAbout FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About PKOH Park-Ohio Holdings Corp.
Park-Ohio Holdings Corp is a company, engaged in industrial supply chain logistics and diversified manufacturing business. It operates in three business segments namely Supply Technologies, Assembly Components and Engineered Products. Geographically, the business of the group is amplifying across the region of the United States, Asia, Europe, Canada, Mexico and others. The company derives key revenue from the Supply Technologies segment which includes proactive solutions approach that manages the efficiencies of every aspect of supplying production parts and materials to customers' manufacturing floor, from strategic planning to program implementation.